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Objective.ToknowthecharacteristicsofendoscopiclaryngealandpharyngealabnormalitiesinJapanesepatientswithlaryngophar-
yngeal reﬂux symptoms (LPRS).Methods. A total of 146 endoscopic images of the larynx and pharynx (60 pairs for the rabeprazole
group and 13 pairs for the control group) were presented to 15 otolaryngologists blinded to patient information and were scored
accordingtoseveralvariables potentiallyassociatedwithlaryngopharyngeal reﬂux.Themedian valueofthe15scoresforeachitem
from each image was obtained. The mean pretreatment scores of each item and total score were assessed in both rabeprazole and
control groups. In the rabeprazole group, the endoscopic ﬁndings before and after the 4-week treatment with rabeprazole were
compared. Changes between corresponding duration in the control group were also evaluated. Results. The median and mean pre-
treatment total score was 3 and 3.02, respectively, from the 73 patients with LPRS. No signiﬁcant diﬀerences were observed before
and after treatment in either the rabeprazole or control groups for any item or total score. In 24 patients with a high pretreatment
score (total score ≥ 4) from the rabeprazole group, signiﬁcant decreases in scores for “thick endolaryngeal mucous” (0.54 to 0.17,
P = 0.017) and total (4.77 to 3.58, P = 0.0003) were observed after the 4-week treatment.
1.Introduction
Gastroesophageal reﬂux is a recognized cause of ENT symp-
toms [1]. Laryngopharyngeal symptoms and signs were re-
ferredtoaslaryngopharyngealreﬂux(LPR)[2].Thelaryngo-
pharyngeal ﬁndings attributed to gastroesophageal reﬂux
have been reported in the posterior pharyngeal wall, true
vocalfolds,andarytenoidmedialwall[3].However,accurate
assessment of signs in the larynx and pharynx is likely to
be diﬃcult because these signs observed during a laryngos-
copic examination cannot be reliably determined from clini-
cian to clinician [4]. The sensitivity and speciﬁcity of laryn-
gopharyngeal ﬁndings, therefore, remain uncertain, chal-
lengingthediagnosticaccuracyofLPR.Inthisstudy,wecon-
ducted a multicenter clinical trial to explore the presence of
endoscopic laryngeal ﬁndings in Japanese patients with lar-
yngopharyngeal reﬂux symptoms (LPRSs). Because the ﬁrst-
line therapy for LPRS is considered to be proton pump inhi-
bitor (PPI) [2], we also compared the endoscopic laryngeal
ﬁndings before and after a 4-week acid suppression therapy.
2. Methods
Subjects consisted of outpatients visiting the otolaryngology
departments of participating institutions between October
2007 and May 2008 who had at least one LPRS such as lump
in the throat, throat pain, irritation in the throat, chronic2 International Journal of Otolaryngology
Table 1: Score for endoscopic laryngeal ﬁndings used in this study.
Findings Score
I n f r a g l o t t i c e d e m a w i t h p s e u d o s u l c u s f o r m a t i o n 0123N E
L a r y n g e a l m u c o s a l e d e m a 0123N E
P o s t e r i o r c o m m i s s u r e h y p e r t r o p h y 0123N E
G r a n u l a t i o n f o r m u l a t i o n 0123N E
T h i c k e n d o l a r y n g e a l m u c o u s 0123N E
R e d n e s s i n t h e i n t r a - a r y t h e n o i d m e d i a l w a l l 0123N E
M u c o u s p o o l i n g i n t h e p y r i f o r m s i n u s 0123N E
NE: not evaluable.
Table 2: Mean scores for pretreatment endoscopic ﬁndings (n =
73).
Endoscopic ﬁndings Total
(n = 73)
RPZ
(n = 60)
Control
(n = 13) P-value
Infraglottic edema
with pseudosulcus
formation
0.39 0.40 0.35 0.776
Laryngeal mucosa
edema 0.52 0.50 0.62 0.471
Posterior
commissure
hypertrophy
0.83 0.88 0.62 0.106
Granulation
formulation 0.15 0.17 0.08 0.362
Thick endolaryngeal
mucous 0.22 0.23 0.15 0.523
Redness in the
intra-arythenoid
medial wall
0.49 0.53 0.31 0.153
Mucous pooling in
the pyriform sinus 0.43 0.43 0.42 0.968
Total 3.02 3.13 2.54 0.258
cough,andhoarsenessandwhoseconsentcouldbeobtained.
A total of 255 endoscopic laryngeal images were presented to
15 otolaryngologists listed in the appendix with the subjects’
names and their before and after therapy status blinded. The
15otolaryngologistsindividuallyscoredonafour-pointscale
as 0 (none), 1 (mild), 2 (moderate), and 3 (severe) or NE
(not evaluable) for ﬁndings potentially associated with LPR,
as shown in Table 1. First 5 of 7 items are derived from the
Reﬂux Finding Score proposed by Belafsky et al. [5] and the
other 2 were from the report by Vaezi et al. [3].
Of the 255 images, 109 were excluded (95, patient over-
lap; 14, number of NE items > 3), and the remaining 146
images were used for further analysis. The median value of
the 15 scores for each item from each subject was obtained.
T h em e a np r e t r e a t m e n ts c o r e so fe a c hi t e ma n dt o t a ls c o r e s
wereassessed.Examplesfortheimageswithhigh(totalscore:
7) and low (total score: 0) median scores were shown in
Figures 1(a) and 1(b), respectively. To 60 patients who were
considered for indication of acid suppression therapy based
on their symptoms, 10mg/day of rabeprazole (RPZ) for 4
weeks was administered and the endoscopic ﬁndings before
and after the 4-week treatment with RPZ were compared.
Table 3:Endoscopicﬁndingsbeforeandafter4weeksinthecontrol
group (n = 13).
Endoscopic ﬁndings Initial 4w e e k s
later P-value
Infraglottic edema with
pseudosulcus formation 0.35 0.46 0.570
Laryngeal mucosa edema 0.62 0.77 0.337
Posterior commissure
hypertrophy 0.62 0.62 1.000
Granulation formulation 0.08 0.08 1.000
Thick endolaryngeal
mucous 0.15 0.31 0.337
Redness in the
intra-arythenoid medial
wall
0.31 0.15 0.337
Mucous pooling in the
pyriform sinus 0.42 0.50 0.838
Total 2.54 3.00 0.239
Table 4: Pre- and posttreatment endoscopic ﬁndings in the RPZ
group (n = 60).
Endoscopic ﬁndings Pretreatment Post-treatment P-value
Infraglottic edema
with pseudosulcus
formation
0.40 0.33 0.419
Laryngeal mucosa
edema 0.50 0.59 0.268
Posterior commissure
hypertrophy 0.88 0.98 0.147
Granulation
formulation 0.17 0.18 0.709
Thick endolaryngeal
mucous 0.23 0.15 0.279
Redness in the
intra-arythenoid
medial wall
0.53 0.62 0.273
Mucous pooling in
the pyriform sinus 0.43 0.37 0.279
Total 3.13 3.20 0.779
Changes between corresponding duration in 13 patients,
who had at least one LPRS and had not received acid sup-
pression therapy, were also evaluated. Double-sided paired
or unpaired t-tests were used to test the signiﬁcance of dif-
ferences.
3. Results
The pretreatment total score for all 73 subjects ranged from
0 to 7 (median score 3, mean score 3.02). No signiﬁcant dif-
ferences were observed between the groups for any item or
total score (RPZ group: 3.12; control group: 2.54, Table 2).
Further, no signiﬁcant diﬀerences were observed before and
after treatment in either the RPZ or control groups for any
itemortotalscore(Tables 3and4).In24patientswithahighInternational Journal of Otolaryngology 3
(a) (b)
Figure 1: Examples for endoscopic laryngeal images with (a) a high score (total score: 7) and (b) a lowest score (total score: 0).
Table 5: Pre- and post-treatment endoscopic ﬁndings in patients
with a total score ≥ 4 from the RPZ group (n = 24).
Endoscopic ﬁndings Pretreatment Post-treatment P-value
Infraglottic edema
with pseudosulcus
formation
0.58 0.38 0.203
Laryngeal mucosa
edema 0.79 0.65 0.307
Posterior commissure
hypertrophy 1.10 0.96 0.166
Granulation
formulation 0.29 0.29 1.000
Thick endolaryngeal
mucous 0.54 0.17 0.017
Redness in the
intra-arythenoid
medial wall
0.83 0.73 0.396
Mucous pooling in
the pyriform sinus 0.63 0.42 0.135
Total 4.77 3.58 0.0003
pretreatmentscore(totalscore ≥4)fromtheRPZgroup,sig-
niﬁcantdecreasesinscoresfor“thickendolaryngealmucous”
(0.54 to 0.17, P = 0.017) and total (4.77 to 3.58, P = 0.0003)
were observed after the 4-week treatment (Table 5).
4. Discussion
The precise laryngoscopic diagnosis of LPR is likely to be
diﬃcult because the examination of abnormalities in the
larynx and the pharynx could be highly subjective [4]. Even
with using gastrointestinal endoscopy which provides clear
images with higher resolution than laryngoscopy, diagnostic
value was limited when evaluating these laryngopharyngeal
lesions in patients with gastroesophageal reﬂux [6]. Some
authors emphasize these ﬁndings in the larynx and pharynx
as being speciﬁc for acid-related problems, others argue that
these may be secondary to other factors such as smoking,
allergies, asthma, viral illness, and voice abuse [3, 7, 8].
During our daily practice in the ENT clinics, we notic-
ed that most of Japanese patients who complain a typical
constellation of LPRS do not necessarily exhibit such laryn-
gopharyngeal abnormal ﬁndings. We also noticed that mini-
mal changes of these ﬁndings are very diﬃcult to be docu-
mented objectively. These small abnormalities cannot be re-
vealed due to the consideration to examiner bias [4, 6]. We
performed this study to ensure objectivity to some extent of
the examination of abnormalities in the larynx and pharynx
in this patient population. We presumed that the median
value of 15 otolaryngologists was the most appropriate value
of each ﬁnding of the laryngopharyngeal abnormality. We
then found a low pretreatment score among the Japanese pa-
tientswithLPRS,suggestingthatmostofthemhadonlymild
laryngeal signs. When limited to the patients with a high
endoscopic laryngeal score, a signiﬁcant decrease in total
score was observed after acid-suppression therapy.
There are some limitations in this study. Among them,
the major one would be the length and the dose of PPI treat-
ment. These could be a possible reason for causing no signi-
ﬁcant diﬀerence before and after the RPZ treatment. The 4
weeksofacidsuppressionwithRPZwithadoseof10mg/day
may not be long or strong enough to see objective improve-
ment. Ford proposed an empirical therapeutic trial using
double-dose, twice-daily PPI for three months [2], suggest-
ing that both the length and the dose of PPI treatment in this
study were not enough to observe signiﬁcant changes in the
laryngopharyngeal ﬁndings.
Currently,onlythepatientswithobviouslaryngopharyn-
geal abnormalities were recruited to the prospective, ran-
domized, double-blind and placebo-controlled studies on4 International Journal of Otolaryngology
the eﬀect of PPI on symptom improvement [9, 10]. In Lam’s
report, there were no signiﬁcant diﬀerences in laryngopha-
ryngeal ﬁndings between the PPI and placebo groups, sug-
gesting that the improvement in laryngeal signs might not
lead to signiﬁcant improvement in patient symptoms. In
other words, laryngeal signs may not correlate faithfully with
actual improvement in LPRS. It may be possible to postulate
that the eﬀect of PPI is not limited to the patients with obvi-
ous laryngopharyngeal abnormalities. The correlation bet-
ween laryngopharyngeal symptoms and signs would need
further studies. Because the precise diagnosis of LPR is still
diﬃcult, it is of critical importance to identify morphologic
or physiologic features more speciﬁc for LPR.
5. Conclusions
The low pretreatment total score of the Japanese patients
with LPRS suggested that most of them had only mild ob-
jective laryngeal signs. In LPRS patients with a high endo-
scopiclaryngealscore,asigniﬁcantdecreaseintotalscorewas
observed after acid suppression therapy.
Appendix
Fifteen otolaryngologists who evaluated endoscopic laryn-
geal images: Nobuhiko Oridate, Yasushi Mesuda, Masanobu
Suzuki (Hokkaido University Hospital), Tomoko Shintani,
Etsuko Kanaizumi (Sapporo Medical University Hospital),
Aya Maruko (Jusendo Hospital), Yusuke Watanabe (Inter-
national University of Health and Welfare Mita Hospital),
Ryoji Tokashiki (Tokyo Medical University Hospital), Yuki
Hamashima, Masanori Yoshioka (Nagoya City University
Hospital), Kiyoto Hosokawa (Kansai Rousai Hospital), Aki
Taguchi (Ehime University Hospital), Rieko Gotoh, Kanako
Indoh (Kagawa University Hospital), and Misako Yamamoto
(Sanuki Municipal Hospital).
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